Drug Profile
YM 53705
Alternative Names: Solifenacin hydrochloride; Solifenacin monohydrochloride; YM-53705Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Yamanouchi
- Class Esters; Irritable bowel syndrome therapies; Isoquinolines; Quinuclidines; Small molecules; Urologics
- Mechanism of Action Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Urinary incontinence
Most Recent Events
- 26 May 1998 Discontinued - Preclinical for Urinary incontinence in Japan (unspecified route)
- 16 May 1997 Preclinical development for Urinary incontinence in Japan (Unknown route)